A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Progyny, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,356 shares of PGNY stock, worth $282,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,356
Holding current value
$282,479
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$16.46 - $30.0 $219,839 - $400,680
13,356 New
13,356 $224,000
Q2 2022

Jul 13, 2022

SELL
$26.06 - $51.94 $101,555 - $202,410
-3,897 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$34.62 - $51.8 $104,448 - $156,280
-3,017 Reduced 43.64%
3,897 $200,000
Q4 2021

Feb 03, 2022

SELL
$46.8 - $66.66 $5,896 - $8,399
-126 Reduced 1.79%
6,914 $348,000
Q3 2021

Nov 02, 2021

BUY
$43.43 - $63.48 $19,804 - $28,946
456 Added 6.93%
7,040 $394,000
Q2 2021

Aug 10, 2021

BUY
$44.87 - $64.95 $295,424 - $427,630
6,584 New
6,584 $388,000

Others Institutions Holding PGNY

About Progyny, Inc.


  • Ticker PGNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 92,080,896
  • Market Cap $1.95B
  • Description
  • Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offe...
More about PGNY
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.